Wei Gen Lu
Director/Board Member at Shanghai Innostar Biotechnology Co., Ltd.
Profile
Wei Gen Lu is currently a Director at Shanghai Innostar Biotechnology Co., Ltd.
He previously worked as a Director at Shanghai Shyndec Pharmaceutical Co., Ltd.
Dr. Lu holds a doctorate degree from East China University of Science & Technology and an undergraduate degree from China Pharmaceutical University.
Wei Gen Lu active positions
Companies | Position | Start |
---|---|---|
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Director/Board Member | 2017-09-30 |
Former positions of Wei Gen Lu
Companies | Position | End |
---|---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Director/Board Member | - |
Training of Wei Gen Lu
China Pharmaceutical University | Undergraduate Degree |
East China University of Science & Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Commercial Services |
- Stock Market
- Insiders
- Wei Gen Lu